Basit öğe kaydını göster

dc.contributor.authorArat, Anıl
dc.contributor.authorAkgul, Erol
dc.contributor.authorOnan, Hasan Bilen
dc.contributor.authorIslek, Irem
dc.contributor.authorTonge, Mehmet
dc.contributor.authorDurmus, Yavuz
dc.contributor.authorBarburoglu, Mehmet
dc.contributor.authorAzizova, Aynur
dc.contributor.authorErol, Cengiz
dc.contributor.authorHakyemez, Bahattin
dc.contributor.authorSencer, Serra
dc.contributor.authorAydin, Kubilay
dc.date.accessioned2021-04-14T05:35:14Z
dc.date.available2021-04-14T05:35:14Z
dc.date.issued2021-01-21
dc.identifier.citationAkgul, E., Onan, H. B., Islek, I., Tonge, M., Durmus, Y., Barburoglu, M., Azizova, A., Erol, C., Hakyemez, B., Sencer, S., Aydin, K., & Arat, A. (2021). Flow diverter stents in the treatment of recanalized intracranial aneurysms. Interventional Neuroradiology. https://doi.org/10.1177/1591019921990507tr_TR
dc.identifier.urihttps://doi.org/10.1177/1591019921990507
dc.identifier.urihttps://journals.sagepub.com/doi/10.1177/1591019921990507
dc.identifier.urihttp://hdl.handle.net/11655/23643
dc.description.abstractAbstract Background: We assessed the safety and efficacy of flow diverter stents (FDSs) in the treatment of recanalized or residual intracranial aneurysms treated endovascularly. Materials & methods: Patients whose recanalized or residual aneurysms were treated with FDSs in five tertiary hospitals were reviewed retrospectively. The patients' demographic data, aneurysm characteristics, types of previous treatment, and clinical complications, or serious adverse events associated with FDSs, as well as the results of neurological and angiographic follow-up assessments, were recorded. Results: Eighty-six patients (37 males) with 87 aneurysms were included in this study. Eighty (91.9%) aneurysms were in the anterior and seven (8.1%) in the posterior circulation. The initial treatment methods were the primary coiling or balloon remodeling technique in 69 (79.3%) and stent-assisted coiling in 18 (20.7%) aneurysms. The endovascular procedure was successful in all patients. Complications occurred in four patients, for a total complication rate of 4.6%. A technical complication developed in one patient (1.2%). An in-stent thrombosis treated with tirofiban was seen in two cases. Late in-stent stenosis exceeding 50% was treated with balloon angioplasty in one patient. The mean length of follow-up was 21.0 months. The first angiographic follow-up (3-6 months) revealed the complete occlusion of 74 aneurysms (85.1%). While 76 aneurysms (87.4%) were occluded at the last angiographic follow-up (mean: 26.0 months), 11 aneurysms (12.6%) were still filling. Morbimortality was zero. Conclusion: The drawback of endovascular treatment is aneurysmal remnants or recurrences, which is safely and durably amenable to flow diversion.tr_TR
dc.language.isoentr_TR
dc.publisherSagetr_TR
dc.relation.isversionof10.1177/1591019921990507tr_TR
dc.rightsinfo:eu-repo/semantics/openAccesstr_TR
dc.rightsAttribution 4.0 United States
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.subjectgirişimsel nöroradyolojitr_TR
dc.subjectRecanalizationtr_TR
dc.subjectcerebral aneurysmtr_TR
dc.subjectresidual aneurysmtr_TR
dc.subjectendovascular treatmenttr_TR
dc.subjectflow divertertr_TR
dc.subject.lcshRadyoloji. Tanısal görüntülemetr_TR
dc.titleFlow diverter stents in the treatment of recanalized intracranial aneurysms.tr_TR
dc.typeinfo:eu-repo/semantics/articletr_TR
dc.typeinfo:eu-repo/semantics/publishedVersiontr_TR
dc.relation.journalInterventional Neuroradiologytr_TR
dc.contributor.departmentRadyolojitr_TR
dc.identifier.volume0tr_TR
dc.identifier.issue0tr_TR
dc.identifier.startpage1tr_TR
dc.identifier.endpage9tr_TR
dc.description.indexPubMedtr_TR
dc.fundingYoktr_TR


Bu öğenin dosyaları:

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster

info:eu-repo/semantics/openAccess
Aksi belirtilmediği sürece bu öğenin lisansı: info:eu-repo/semantics/openAccess